Topadur Pharma

Switzerland - Schlieren

Pharmaceutical

WebsiteLinkedInCareers Page

Focus: Compounds Targeting cGMP-Enzyme Regulation System

Topadur Pharma AG is a clinical-stage company developing novel therapies to restore healthy blood flow and stimulate tissue regeneration. We focus on challenging-to-treat age-related diseases characterized by microvascular dysfunction and impaired healing. With a precision-targeted approach, we aim for localized healing with minimal systemic exposure.